Venture Certified
| 기술평가보증기업(기금) | 2018-09-21 ~ 2020-09-20 | 20180111212 | 2018-09-21 |
| 벤처투자유형 | 2020-09-21 ~ 2022-09-20 | 20200300940 | 2018-09-21 |
| 벤처투자유형 | 2022-09-21 ~ 2025-09-20 | 20220817010042 | 2018-09-21 |
| 벤처투자유형 | 2025-09-21 ~ 2028-09-20 | 20251028010020 | 2018-09-21 |
Revenue CAGR +52.3%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 0.0B | 1.8B | 1.2B |
| Operating Profit | -98.5B | -131.8B | -130.8B |
| Net Profit | -129.6B | -194.2B | -144.7B |
| Total Assets | 97.0B | 192.3B | 209.9B |
| Total Liabilities | 892.9B | 863.6B | 694.1B |
| Total Equity | -795.9B | -671.3B | -484.1B |
Capital Erosion: Total equity is negative or below 50% of capital stock
Operating Loss: Op. profit -98B
Revenue down 100% YoY
3 Consecutive Years of Net Loss
▼ 100.0%
▲ 25.0%
▲ 17.5%
▼ 44.6%
| Name | Position | Role |
|---|---|---|
| 최시우 | 대표이사 | 대표 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "대구광역시 북구",
"ceo_name": "최시우",
"certificate": [
{
"cert_number": "20180111212",
"changes": "",
"disclosure_date": "2018-09-21",
"first_cert_date": "2018-09-21",
"no": "1",
"type": "기술평가보증기업(기금)",
"valid_period": "2018-09-21 ~ 2020-09-20"
},
{
"cert_number": "20200300940",
"changes": "",
"disclosure_date": "2020-08-13",
"first_cert_date": "2018-09-21",
"no": "2",
"type": "벤처투자유형",
"valid_period": "2020-09-21 ~ 2022-09-20"
},
{
"cert_number": "20220817010042",
"changes": "",
"disclosure_date": "2022-08-17",
"first_cert_date": "2018-09-21",
"no": "3",
"type": "벤처투자유형",
"valid_period": "2022-09-21 ~ 2025-09-20"
},
{
"cert_number": "20251028010020",
"changes": "",
"disclosure_date": "2025-10-28",
"first_cert_date": "2018-09-21",
"no": "4",
"type": "벤처투자유형",
"valid_period": "2025-09-21 ~ 2028-09-20"
}
],
"company_name": "(주)업테라",
"corp_no": "120111-*******",
"financials": {
"2022": {
"capital_stock": 1258401000,
"cost_of_sales": 0,
"current_assets": 16241942000,
"current_liabilities": 39181457000,
"gross_profit": 116157000,
"net_income": -14467771000,
"net_income_bs": -14467771000,
"non_current_assets": 4750041000,
"non_current_liabilities": 30224568000,
"non_operating_expenses": 1606323000,
"non_operating_income": 219178000,
"operating_profit": -13080626000,
"revenue": 116157000,
"sga_expenses": 13196783000,
"total_assets": 20991983000,
"total_equity": -48414043000,
"total_liabilities": 69406026000
},
"2023": {
"capital_stock": 1263621000,
"cost_of_sales": 0,
"current_assets": 14819824000,
"current_liabilities": 85027135000,
"gross_profit": 176951000,
"net_income": -19415166000,
"net_income_bs": -19415166000,
"non_current_assets": 4405773000,
"non_current_liabilities": 1330224000,
"non_operating_expenses": 6898989000,
"non_operating_income": 663140000,
"operating_profit": -13179317000,
"revenue": 176951000,
"sga_expenses": 13356268000,
"total_assets": 19225597000,
"total_equity": -67131762000,
"total_liabilities": 86357359000
},
"2024": {
"capital_stock": 1263621000,
"cost_of_sales": 0,
"current_assets": 6182743000,
"current_liabilities": 87460126000,
"gross_profit": 0,
"net_income": -12958461000,
"net_income_bs": -12958461000,
"non_current_assets": 3515176000,
"non_current_liabilities": 1829238000,
"non_operating_expenses": 8848778000,
"non_operating_income": 5738495000,
"operating_profit": -9848178000,
"revenue": 0,
"sga_expenses": 9848178000,
"total_assets": 9697919000,
"total_equity": -79591445000,
"total_liabilities": 89289364000
}
},
"industry": "의학 및 약학 연구개발업",
"investment": [
{
"amount": "500,000,000",
"changes": "500,000,000",
"date": "2022-05-13"
},
{
"amount": "500,019,000",
"changes": "500,019,000",
"date": "2022-05-13"
},
{
"amount": "500,019,000",
"changes": "500,019,000",
"date": "2022-05-13"
},
{
"amount": "500,000,000",
"changes": "500,000,000",
"date": "2022-05-13"
},
{
"amount": "2,500,000,000",
"changes": "2,500,000,000",
"date": "2021-12-28"
},
{
"amount": "2,500,000,000",
"changes": "2,500,000,000",
"date": "2021-12-28"
},
{
"amount": "3,000,000,000",
"changes": "3,000,000,000",
"date": "2020-09-11"
},
{
"amount": "2,500,016,000",
"changes": "2,500,016,000",
"date": "2020-06-11"
},
{
"amount": "1,000,000,000",
"changes": "1,000,000,000",
"date": "2020-06-11"
},
{
"amount": "500,007,300",
"changes": "500,007,300",
"date": "2020-06-11"
},
{
"amount": "1,500,009,600",
"changes": "1,500,009,600",
"date": "2020-06-11"
},
{
"amount": "1,500,000,000",
"changes": "1,500,000,000",
"date": "2020-06-11"
},
{
"amount": "1,000,000,000",
"changes": "1,000,000,000",
"date": "2020-06-11"
},
{
"amount": "499,999,500",
"changes": "499,999,500",
"date": "2019-04-30"
}
],
"main_products": "의약품",
"phone": "032-822-****",
"years": [
2024,
2023,
2022
]
}Data Quality: 8/10 | Primary Source: Venture System | Section Coverage: 6/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | Public Data | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Not Collected | Not Collected |
| Officers | Public Data | Collected |
| Employment | Not Collected | Not Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| G2B Procurement | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |
| Venture System Detail | 2026-02-25 | Collected |